---
type: "Symbol"
title: "Bristol Myers Squibb (BMY.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/BMY.US/topics.md"
symbol: "BMY.US"
parent: "https://longbridge.com/en/quote/BMY.US.md"
count: 18
datetime: "2026-06-10T04:06:44.021Z"
locales:
  - [en](https://longbridge.com/en/quote/BMY.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BMY.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BMY.US/topics.md)
---

# Bristol Myers Squibb (BMY.US) — Community Discussions

### [📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $Bristol Myers Squibb(BMY.US) Br…](https://longbridge.com/en/topics/40945128.md)

- Author: [Hardik Shah](https://longbridge.com/en/profiles/27423834.md)
- Datetime: 2026-05-20T10:57:27.000Z
- Comments: 0
- 📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $Bristol Myers Squibb(BMY.US) Bristol-Myers Squibb (BMY) brings Anthropic's Claude to 30,000 of its staff - WSJ

### [Everyone, please pay attention to pharmaceutical c…](https://longbridge.com/en/topics/40021748.md)

- Author: [30年河东30年河西](https://longbridge.com/en/profiles/12268461.md)
- Datetime: 2026-04-18T20:36:10.000Z
- Comments: 0
- Everyone, please pay attention to pharmaceutical companies.

### [$Bristol Myers Squibb(BMY.US)Which one should I ch…](https://longbridge.com/en/topics/38786934.md)

- Author: [tCjH](https://longbridge.com/en/profiles/16951307.md)
- Datetime: 2026-02-19T14:58:40.000Z
- Comments: 0
- $Bristol Myers Squibb(BMY.US)Which one should I choose over Pfizer? Please advise, boss.

### [Mark，](https://longbridge.com/en/topics/38786827.md)

- Author: [十袋红利](https://longbridge.com/en/profiles/17867290.md)
- Datetime: 2026-02-19T14:55:51.000Z
- Comments: 0
- Mark，

### [Isn't this simple? Isn't this difficult?](https://longbridge.com/en/topics/38782879.md)

- Author: [浩浩荡荡地](https://longbridge.com/en/profiles/19784218.md)
- Datetime: 2026-02-19T09:37:57.000Z
- Comments: 1
- Isn't this simple? Isn't this difficult?

**Comments:**

- **Standard Feng · 2026-02-19T13:55:41.000Z**: Citi is indeed good.

### [Losses remain, but the story isn't over: InventisBio seeks second capital pricing in the southbound market](https://longbridge.com/en/topics/37918054.md)

- Author: [港股研究社](https://longbridge.com/en/profiles/3199113.md)
- Datetime: 2026-01-19T07:30:43.000Z
- Comments: 0
- In July 2022, InventisBio was listed on the STAR Market at 18.12 yuan per share, with its first-day plunge of 23% becoming a microcosm of the bursting valuation bubble of innovative pharmaceutical com

### [Breakthrough in autoimmune BTK and lupus research](https://longbridge.com/en/topics/37222984.md)

- Author: [锦缎研究院](https://longbridge.com/en/profiles/2576456.md)
- Datetime: 2025-12-18T04:19:16.000Z
- Comments: 0
- 2025 is hailed as the "Year of Autoimmunity" for BTK inhibitors. Following the FDA approval of Sanofi's BTK inhibitor Rilzabrutinib in late August this year for the treatment of primary immune

### [The wind has changed! 'Barron's' 2026 top picks list shows a 'great retreat', abandoning AI for these 10 defensive stocks?](https://longbridge.com/en/topics/37202036.md)

- Author: [投資從零開始 (Andy)](https://longbridge.com/en/profiles/12189443.md)
- Datetime: 2025-12-17T14:41:01.000Z
- Comments: 0
- Barron's has just released its 2026 stock picks list, showing a major shift in style. You don't need to go through the 2025 list one by one—I've already summarized it for you👇​2026 is completely diff

### [Topic #37115611](https://longbridge.com/en/topics/37115611.md)

- Author: [猫的名字叫奥利奥](https://longbridge.com/en/profiles/15248623.md)
- Datetime: 2025-12-13T03:14:33.000Z
- Comments: 1

**Comments:**

- **,k.. · 2025-12-18T14:48:09.000Z**: What does the second paragraph mean? Please explain.

### [$Pharmaceuticals(IN00372.US)2025.12.11, tech stock…](https://longbridge.com/en/topics/37069883.md)

- Author: [Fifty_Gulagデ](https://longbridge.com/en/profiles/15598476.md)
- Datetime: 2025-12-11T15:16:57.000Z
- Comments: 0
- $Pharmaceuticals(IN00372.US)2025.12.11, tech stocks fell across the board🧐, record

### [$Bristol Myers Squibb(BMY.US)Just call you Meibao](https://longbridge.com/en/topics/37057009.md)

- Author: [Saury](https://longbridge.com/en/profiles/13335231.md)
- Datetime: 2025-12-11T06:02:34.000Z
- Comments: 0
- $Bristol Myers Squibb(BMY.US)Just call you Meibao

### [Recently, $Meta Platforms(META.US) and $Constellat…](https://longbridge.com/en/topics/36954766.md)

- Author: [时雨](https://longbridge.com/en/profiles/14914978.md)
- Datetime: 2025-12-05T17:00:58.000Z
- Comments: 0
- Recently, $Meta Platforms(META.US) and $Constellation Brands(STZ.US) have performed well, quite satisfied. The only regret is buying too little STZ, will consider more if there's a chance.Today took a

### [CELG.RT.US What? I really thought no one would loo…](https://longbridge.com/en/topics/36876804.md)

- Author: [力咖](https://longbridge.com/en/profiles/7200108.md)
- Datetime: 2025-12-03T10:23:14.000Z
- Comments: 0
- CELG.RT.US What? I really thought no one would look at such a niche stock, but it surged so much all of a sudden. Can someone explain? Could there be insider news?

### [Sichuan's new richest man "won't sell" Hong Kong stocks, Baili Tianheng's 4.8 billion funding concerns](https://longbridge.com/en/topics/36460096.md)

- Author: [阿尔法工场](https://longbridge.com/en/profiles/5044766.md)
- Datetime: 2025-11-18T06:24:32.000Z
- Comments: 1
- Introduction: $BIOKIN(02615.HK) faces a funding gap of over 4.8 billion yuan in the next three years but delays its IPO in Hong Kong. Where does Zhu Yi, the "new richest man in Sichuan," get h

**Comments:**

- **Saury · 2025-11-24T16:07:57.000Z**: ADC is highly toxic

### [Not saying how much was earned, but never lost](https://longbridge.com/en/topics/36405056.md)

- Author: [吴之味](https://longbridge.com/en/profiles/13287771.md)
- Datetime: 2025-11-15T03:57:23.000Z
- Comments: 0
- Not saying how much was earned, but never lost

### [Can the commission fees for buying and selling sto…](https://longbridge.com/en/topics/36402947.md)

- Author: [吴之味](https://longbridge.com/en/profiles/13287771.md)
- Datetime: 2025-11-15T01:11:50.000Z
- Comments: 3
- Can the commission fees for buying and selling stocks be included in the displayed holding cost? Otherwise, every transaction ignores this fee, making it seem like a profit when in reality there isn't

**Comments:**

- **1+1=2 · 2026-05-26T14:18:06.000Z**: Don't let your high-frequency trading end up with all the profits eaten by commissions.
- **关大月朵 · 2026-04-04T08:35:10.000Z**: Agree

### [[HK IPO] Baili Tianheng, another A+H share with a lot size of nearly HKD 40k is a bit scary](https://longbridge.com/en/topics/36174457.md)

- Author: [小散老俞](https://longbridge.com/en/profiles/3011188.md)
- Datetime: 2025-11-09T11:42:18.000Z
- Comments: 0
- The company is a comprehensive healthcare enterprise group with capabilities in early-stage R&D, clinical development, production, and commercialization. During the track record period, we operate

### [HK IPO Subscription | Baili Tianheng Secures a Major Overseas Order Worth 60 Billion for Innovative Drugs!](https://longbridge.com/en/topics/36133094.md)

- Author: [Owen聊投资](https://longbridge.com/en/profiles/16287079.md)
- Datetime: 2025-11-07T11:04:29.000Z
- Comments: 1
- Want to see $BIOKIN(02615.HK) Conclusion at the bottom～【IPO Details】Two points to note: ①Baili Tianheng is listed as an AH share but without a greenshoe option, qualifying for fast-track inclusion rul

**Comments:**

- **Wwwfen · 2025-11-10T03:04:16.000Z**: Not playing this one

## References

- [Bristol Myers Squibb (BMY.US)](https://longbridge.com/en/quote/BMY.US.md)